Immunotherapy (NHS-IL12 & Bintrafusp Alfa) and Radiation Therapy for the Treatment of Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer, the REINA Trial

Name: Immunotherapy (NHS-IL12 & Bintrafusp Alfa) and Radiation Therapy for the Treatment of Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer, the REINA Trial
License: Public Domain

M.D. Anderson Cancer Center

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

anatomic stage iv breast cancer ajcc v8, hormone receptor positive breast adenocarcinoma, metastatic breast carcinoma, metastatic her2 negative breast adenocarcinoma, prognostic stage iv breast cancer ajcc v8

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 460103
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.